B. Braun Launches Midazolam in 0.8% Sodium Chloride Injection with Enhanced Safety and Usability Features

BETHLEHEM, Pa., Oct. 15, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a recognized leader in infusion therapy and pharmaceutical manufacturing, announced the launch of Midazolam in 0.8% Sodium Chloride Injection in the U.S. market. The preservative-free injections will be...